[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100526084":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":10,"responsibleParty":25,"collaborators":28,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":10,"eligibilityCriteria":39,"healthyVolunteers":35,"sex":40,"minAge":41,"maxAge":10,"enrollmentInfo":42,"targetDuration":10,"studyType":45,"phases":10,"briefSummary":46,"conditions":47,"keywords":10,"overallStatus":51,"whyStopped":10,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":10},{"fullName":5,"class":6},"Kangbuk Samsung Hospital","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"HIV",null,"Patients with HIV infection",{"label":13,"type":10,"description":14,"interventionNames":10},"HBV","Patients with HBV infection",[16],{"name":17,"affiliation":5,"role":18},"Eunjeong Joo, M.D., Ph.D","PRINCIPAL_INVESTIGATOR",[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Bomi Kim, M.D.","CONTACT","82-10-8797-7558","springi02@naver.com",{"type":18,"investigatorFullName":26,"investigatorTitle":27,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Eun-Jeong Joo","M.D, Ph.D",[29,31],{"name":30,"class":6},"Kyunghee University Medical Center",{"name":32,"class":6},"Hanyang University","100526084","gut-microbiome-in-people-living-with-hiv-and-hbv-100526084",false,"NCT06130137","Gut Microbiome in People Living With HIV and HBV","Genome-based Multiomics Analysis on Gut Microbiome in People Living With HIV and HBV","Inclusion Criteria:\n\n1. HIV patients\n\n   * Inidividuals over 19 years old\n   * HIV patients on antiretroviral therapy (ART)\n2. HBV patients\n\n   * Individuals over 19 years old\n   * Chronic hepatitis B patients with either chronic hepatitis, liver cirrhosis or hepatocellular carcinoma\n\nExclusion Criteria:\n\n1. Patients with indeterminate colitis\n2. Individuals who have used antibiotics or steroids within 24 hours of the microbiome sample collection (excluding antiviral treatments for hepatitis B and HIV)\n3. Individuals who have used vaginal or external medications, including antifungal agents, within 24 hours of microbiome sample collection\n4. Those with acute illnesses, with or without fever, of moderate or severe severity; however, sampling may be postponed until the subject recovers.\n5. Individuals with gastrointestinal disorders that may impact microbiome analysis and are currently medically uncontrolled or under treatment for the respective condition\n6. Individuals with a positive result in a urine pregnancy test, pregnant, or breastfeeding at the time of microbiome sample collection\n7. Individuals for whom medical opinions suspect that they may have an impact on the sample collection at the time of microbiome collection.","ALL","19 Years",{"count":43,"type":44},200,"ESTIMATED","OBSERVATIONAL","Building a Microbiome Data Platform and Conducting Clinical Evidence Research in Individuals Infected with the Human Immunodeficiency Virus (HIV) and Hepatitis B virus.",[48,49,50],"Human Immunodeficiency Virus","Chronic Hepatitis b","Gut Microbiome","NOT_YET_RECRUITING","2023-11-08",{"date":54,"type":55},"2023-11-14","ACTUAL",{"date":57,"type":44},"2023-11-27",{"date":59,"type":44},"2027-12-31",{"name":5,"class":6}]